Programs Search and Views Navigation
March 2022
- UPCOMING LIVE PROGRAMS
A Family Physician’s Guide for Early Detection of Cognitive Impairment and Alzheimer’s Disease: Moving Towards Earlier Recognition and Improved Management
What do family physicians need to know about caring for patients with Alzheimer’s disease (AD)? Family physicians are well positioned to spot the earliest signs of cognitive decline—and patients are more likely to discuss cognitive concerns with a clinician they know and trust. This session will provide you with the latest information regarding screening for AD-related dementia, diagnostic best practices, efficacy and safety data of recently approved and emerging therapeutic agents, and effective communication strategies. You will leave this 1-hour…
Find out more »April 2022
- UPCOMING LIVE PROGRAMS
A Family Physician’s Guide for Early Detection of Cognitive Impairment and Alzheimer’s Disease: Moving Towards Earlier Recognition and Improved Management
What do family physicians need to know about caring for patients with Alzheimer’s disease (AD)? Family physicians are well positioned to spot the earliest signs of cognitive decline—and patients are more likely to discuss cognitive concerns with a clinician they know and trust. This session will provide you with the latest information regarding screening for AD-related dementia, diagnostic best practices, efficacy and safety data of recently approved and emerging therapeutic agents, and effective communication strategies. You will leave this 1-hour…
Find out more »June 2022
- UPCOMING LIVE PROGRAMS
A Family Physician’s Guide for Early Detection of Cognitive Impairment and Alzheimer’s Disease: Moving Towards Earlier Recognition and Improved Management
What do family physicians need to know about caring for patients with Alzheimer’s disease (AD)? Family physicians are well positioned to spot the earliest signs of cognitive decline—and patients are more likely to discuss cognitive concerns with a clinician they know and trust. This session will provide you with the latest information regarding screening for AD-related dementia, diagnostic best practices, efficacy and safety data of recently approved and emerging therapeutic agents, and effective communication strategies. You will leave this 1-hour…
Find out more »